GOLDMAN SACHS GROUP INC - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,698,068
-42.4%
592,477
-34.6%
0.00%
-40.0%
Q2 2023$23,770,239
+100.3%
906,569
+96.6%
0.01%
+66.7%
Q1 2023$11,867,092
+19.4%
461,037
+20.6%
0.00%
+50.0%
Q4 2022$9,940,710
-28.2%
382,188
-21.3%
0.00%
-33.3%
Q3 2022$13,847,000
+107.8%
485,353
+79.3%
0.00%
+50.0%
Q2 2022$6,665,000
-47.0%
270,687
+21.5%
0.00%
-33.3%
Q1 2022$12,569,000
-8.8%
222,709
+0.2%
0.00%0.0%
Q4 2021$13,778,000
-0.1%
222,307
+2.3%
0.00%0.0%
Q3 2021$13,789,000
-9.9%
217,363
+17.0%
0.00%0.0%
Q2 2021$15,308,000
+48.6%
185,753
+32.7%
0.00%0.0%
Q1 2021$10,299,000
-59.0%
139,987
-59.5%
0.00%
-50.0%
Q4 2020$25,092,000
+5831.9%
346,004
+3796.0%
0.01%
Q3 2020$423,000
-78.7%
8,881
-81.2%
0.00%
-100.0%
Q2 2020$1,985,000
+80.5%
47,250
-6.9%
0.00%
Q3 2019$1,100,00050,7600.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 7,281,307$347,100,00032.35%
BVF INC/IL 2,053,991$97,914,0005.33%
Samsara BioCapital, LLC 398,017$18,973,0005.29%
Orbimed Advisors 7,406,307$353,059,0004.44%
Consonance Capital Management LP 602,732$28,732,0003.50%
Boxer Capital, LLC 2,075,905$98,958,0003.42%
Perceptive Advisors 3,481,148$165,946,0002.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,234,262$58,837,0001.43%
DRIEHAUS CAPITAL MANAGEMENT LLC 974,915$46,474,0000.95%
HighVista Strategies LLC 11,477$547,0000.40%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders